It is our great pleasure to invite you to take part at MSS2026. Join us!
MSS2026 focuses on production solutions across the full journey—from development to manufacturing—together with advanced analytics for gene therapies, vaccines, and complex biological products such as plasma, proteins, and enzymes.
The symposium covers the entire workflow, from upstream to downstream processing, in a hybrid format that supports both onsite and online participation.
MSS2026 Speakers
Dan Peer
Laboratory of Precision Nanomedicine, Tel Aviv University, Israel
The RNA revolution: from novel vaccines to therapeutic genome editing
Stefano Menegatti
North Carolina State University, USA
Affinity and mixed-mode convective adsorbents for the purification and enrichment of vectors for cell and gene therapies
Andre Germishuizen
National Bioproducts Institute (NBI), South Africa
Commercial scale evaluation of a mixed mode CIMmultus® monolithic column in the production of human immunoglobulin products
Christy Franco
VGXI, USA
Commercial-ready plasmid manufacturing: scaling late-stage cell & gene therapy with regulatory confidence
Jacek Lubelski
NanoCell, Netherlands
tLNP as a novel gene therapy vector to deliver DNA – are we there yet?
Manuela Bartolini
University of Bologna, Italy
Monolith-based immobilized enzyme reactors: enabling technologies for diverse and evolving landscapes
Thomas Muster
BlueSky Immunotherapies, Austria
delNS – an interferon inducing viral vector to tackle head & neck cancer
Yijun Zhou
National Institutes of Health (NIH), USA
Monitoring mRNA vaccine process development using PATfix HPLC
Aleš Štrancar
BIA Separations Inc, USA
Away from Cohn, away from EtOH, the next generation plasma fractionation process
REGISTER
MSS2026 is about Bridging Science, Innovation and Manufacturing in Bioprocessing and Biopharma. Will you be part of it?
REGISTER HERE
MSS2024 OVERVIEW
Take a look at previous editions and hear what past participants had to say.
GET A MSS2024 OVERVIEW
